Kiwi Wealth Investments Limited Partnership Eli Lilly & CO Transaction History

Kiwi Wealth Investments Limited Partnership

$126 Million
Q4 2023

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$350.74 - $468.98 $5.49 Million - $7.34 Million	-15,661 Reduced 23.0%	52,429 $24.6 Million
Q1 2023 May 15, 2023	BUY	$310.63 - $364.82 $3.06 Million - $3.59 Million	9,846 Added 16.9%	68,090 $23.4 Billion
Q4 2022 Feb 14, 2023	BUY	$321.55 - $374.67 $6.52 Million - $7.59 Million	20,271 Added 53.38%	58,244 $21.3 Billion
Q2 2022 Aug 12, 2022	BUY	$278.73 - $327.27 $2.61 Million - $3.06 Million	9,363 Added 32.73%	37,973 $12.3 Million
Q1 2022 May 17, 2022	SELL	$234.69 - $291.66 $3.34 Million - $4.15 Million	-14,231 Reduced 33.22%	28,610 $8.19 Million
Q4 2021 Feb 15, 2022	SELL	$224.85 - $279.04 $4.32 Million - $5.36 Million	-19,193 Reduced 30.94%	42,841 $11.8 Million
Q3 2021 Nov 16, 2021	SELL	$221.6 - $272.71 $2.52 Million - $3.11 Million	-11,389 Reduced 15.51%	62,034 $14.3 Million
Q2 2021 Aug 17, 2021	SELL	$180.55 - $233.54 $2.45 Million - $3.17 Million	-13,579 Reduced 15.61%	73,423 $16.9 Million
Q1 2021 May 18, 2021	BUY	$164.32 - $212.72 $3.93 Million - $5.08 Million	23,889 Added 37.85%	87,002 $16.3 Million
Q4 2020 Feb 17, 2021	BUY	$130.46 - $172.63 $3.52 Million - $4.66 Million	27,014 Added 74.83%	63,113 $10.7 Million
Q3 2020 Nov 16, 2020	SELL	$146.22 - $169.13 $2.58 Million - $2.98 Million	-17,622 Reduced 32.8%	36,099 $5.34 Million
Q2 2020 Aug 14, 2020	BUY	$136.42 - $164.18 $5.09 Million - $6.12 Million	37,290 Added 226.95%	53,721 $8.82 Million
Q1 2020 May 15, 2020	SELL	$119.05 - $147.35 $599,773 - $742,349	-5,038 Reduced 23.47%	16,431 $2.28 Million
Q4 2019 Feb 12, 2020	SELL	$106.92 - $132.43 $1.46 Million - $1.8 Million	-13,623 Reduced 38.82%	21,469 $2.82 Million
Q3 2019 Nov 13, 2019	BUY	$106.79 - $116.16 $98,780 - $107,448	925 Added 2.71%	35,092 $3.92 Million
Q2 2019 Aug 14, 2019	SELL	$110.79 - $129.32 $456,454 - $532,798	-4,120 Reduced 10.76%	34,167 $3.79 Million
Q1 2019 May 16, 2019	SELL	$111.31 - $131.02 $1.21 Million - $1.42 Million	-10,830 Reduced 22.05%	38,287 $4.97 Million
Q4 2018 Feb 14, 2019	BUY	$105.9 - $118.64 $5.2 Million - $5.83 Million	49,117 New	49,117 $5.68 Million
Q3 2018 Nov 15, 2018	SELL	$85.86 - $107.31 $5.13 Million - $6.41 Million	-59,748 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$75.7 - $86.88 $4.52 Million - $5.19 Million	59,748 New	59,748 $5.1 Million

Others Institutions Holding LLY

# of Institutions

4,004

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

Lilly Endowment Inc Indianapolis, IN

96.9M
Shares

$72.5 Billion
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

73.8M
Shares

$55.2 Billion
1.2% of portfolio
Black Rock Inc. New York, NY

65.9M
Shares

$49.3 Billion
1.37% of portfolio
Pnc Financial Services Group, Inc. Pittsburgh, PA

51.4M
Shares

$38.4 Billion
29.2% of portfolio
State Street Corp Boston, MA

33.9M
Shares

$25.3 Billion
1.24% of portfolio

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $711B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kiwi Wealth Investments Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Kiwi Wealth Investments Limited Partnership with notifications on news.

Account